Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001567619-22-009698)

Filing Details

Accession Number:: 0001567619-22-009698
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-05-06 17:14:07
Reporting Period:: 2021-10-15

Accepted Time:: 2022-05-06 17:14:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1509261	Rezolute Inc.	RZLT	Pharmaceutical Preparations (2834)	273440894

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1755074	Wladimir Hogenhuis	C/O Rezolute, Inc. 201 Redwood Shores Parkway, Suite 315 Redwood City CA 94065		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-10-15	7,693	$6.50	7,693	No	4	P	Direct
Common Stock	Acquisiton	2022-05-04	25,000	$3.80	32,693	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The Reporting Person acquired these shares of common stock in connection with the Issuer's closing of registered direct public offering on May 4, 2022.